FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approves a supplemental application for UROXATRAL (alfuzosin HCl) from Advanz Pharma US Corp. The approval relates to updates to the product for the treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Uroxatral (Alfuzosin)

Snippet

SUPPL AP for UROXATRAL (ALFUZOSIN HCL)